CD4 and neoplasm: Disrupting the interaction between CTLs and CD4+ T cells through HLA-DR blockade or CD4+ T cells depletion may compromise anti-tumor immune responses, suggesting a critical role for both HLA-DR and CD4+ T cells in CTLs activation and cytotoxic capabilities.